FDA Adverse Event Malfunction Summary report: N

FINELINE II

MDR report key: 3041157 · Received April 8, 2013

Report

Report Number
2124215-2013-01249
Event Type
Malfunction
Date Received
April 8, 2013
Date of Event
January 9, 2013
Report Date
February 19, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
PMA / PMN Number
P960004
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS DEVICE SYSTEM DETECTED A LEAD SAFETY SWITCH ON THE RIGHT VENTRICULAR (RV) LEAD GREATER THAN 2,500 OHMS IN THE UNIPOLAR AND BIPOLAR CONFIGURATIONS. THE SALES REPRESENTATIVE WAS TO FURTHER DISCUSS WITH THE PATIENTS PHYSICIAN. INFORMATION WAS RECEIVED THAT TO DATE, NO X-RAY WAS PERFORMED, HOWEVER, THE PATIENT WAS TO BE SCHEDULED FOR A LEAD REVISION PROCEDURE. TO DATE, NO ADVERSE PATIENT EFFECTS WERE REPORTED AS A RESULT OF THIS CLINICAL OBSERVATION.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED FROM THE PATIENT WITH THIS LEAD THAT FOLLOWING A FALL ONTO A PADDED KNOB, THE PATIENT BEGAN TO FEEL DIFFERENT ONCE THE LEAD HAD FRACTURED. THE PATIENT ALSO NOTED THAT ONCE THE LEAD WAS FRACTURED, THE PHYSICIAN ALSO DISCOVERED THE PATIENT WAS ENDURING ATRIAL FIBRILLATION (AF).

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED THAT A REVISION PROCEDURE WAS PERFORMED. THE RV LEAD WAS OBSERVED TO BE FRACTURED, RESULTING IN THE PACING IMPEDANCE MEASUREMENTS GREATER THAN 2,500 OHMS. THE RV LEAD WAS SURGICALLY ABANDONED AND REPLACED WITHOUT COMPLICATION. NO ADVERSE PATIENT EFFECTS WERE REPORTED DURING THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
143132 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4457

Patients

Seq Age Sex Outcome Treatment
1 83 YR 4457| 1290| 4480